Chinese Biotech Breakthroughs

Results

1 new

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

4 companies

Dizal (Jiangsu) Pharmaceutical

Market Cap: CN¥26.1b

A biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of cancer and immunological diseases.

688192

CN¥56.20

-3.1%

-2.1%

Nanjing Vazyme Biotech

Market Cap: CN¥7.7b

Offers technology solutions for life science, biomedicine, and in vitro diagnostics.

688105

CN¥19.46

3.3%

-15.8%

Chongqing Genrix Biopharmaceutical

Market Cap: CN¥11.5b

A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs in China.

688443

CN¥31.38

3.4%

14.6%

Suzhou Zelgen Biopharmaceuticals

Market Cap: CN¥26.5b

Engages in the research, development, manufacture, sale, and distribution of medicines in the People's Republic of China.

688266

CN¥100.00

-1.2%